Literature DB >> 36052215

An extended and unified modeling framework for benchmark dose estimation for both continuous and binary data.

Marc Aerts1, Matthew W Wheeler2, José Cortiñas Abrahantes3.   

Abstract

Protection and safety authorities recommend the use of model averaging to determine the benchmark dose approach as a scientifically more advanced method compared with the no-observed-adverse-effect-level approach for obtaining a reference point and deriving health-based guidance values. Model averaging however highly depends on the set of candidate dose-response models and such a set should be rich enough to ensure that a well-fitting model is included. The currently applied set of candidate models for continuous endpoints is typically limited to two models, the exponential and Hill model, and differs completely from the richer set of candidate models currently used for binary endpoints. The objective of this article is to propose a general and wide framework of dose response models, which can be applied both to continuous and binary endpoints and covers the current models for both type of endpoints. In combination with the bootstrap, this framework offers a unified approach to benchmark dose estimation. The methodology is illustrated using two data sets, one with a continuous and another with a binary endpoint.

Entities:  

Keywords:  Akaike information criterion; benchmark dose; bootstrap; cumulative distribution function; dose response; maximum likelihood; model averaging

Year:  2020        PMID: 36052215      PMCID: PMC9432821          DOI: 10.1002/env.2630

Source DB:  PubMed          Journal:  Environmetrics        ISSN: 1099-095X            Impact factor:   1.527


  11 in total

Review 1.  Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1.

Authors:  J Allen Davis; Jeffrey S Gift; Q Jay Zhao
Journal:  Toxicol Appl Pharmacol       Date:  2010-10-27       Impact factor: 4.219

2.  Model averaging using fractional polynomials to estimate a safe level of exposure.

Authors:  Christel Faes; Marc Aerts; Helena Geys; Geert Molenberghs
Journal:  Risk Anal       Date:  2007-02       Impact factor: 4.000

3.  Properties of model-averaged BMDLs: a study of model averaging in dichotomous response risk estimation.

Authors:  Matthew W Wheeler; A John Bailer
Journal:  Risk Anal       Date:  2007-06       Impact factor: 4.000

4.  Model Uncertainty and Bayesian Model Averaged Benchmark Dose Estimation for Continuous Data.

Authors:  Kan Shao; Jeffrey S Gift
Journal:  Risk Anal       Date:  2013-06-11       Impact factor: 4.000

Review 5.  Shape and steepness of toxicological dose-response relationships of continuous endpoints.

Authors:  Wout Slob; R Woodrow Setzer
Journal:  Crit Rev Toxicol       Date:  2013-11-19       Impact factor: 5.635

6.  A new method for determining allowable daily intakes.

Authors:  K S Crump
Journal:  Fundam Appl Toxicol       Date:  1984-10

7.  The Impact of Model Uncertainty on Benchmark Dose Estimation.

Authors:  R Webster West; Walter W Piegorsch; Edsel A Peña; Lingling An; Wensong Wu; Alissa A Wickens; Hui Xiong; Wenhai Chen
Journal:  Environmetrics       Date:  2012-12       Impact factor: 1.900

8.  Ranking of allergenic potency of rubber chemicals in a modified local lymph node assay.

Authors:  Wim H De Jong; François M M Van Och; Constance F Den Hartog Jager; Sander W Spiekstra; W Slob; Rob J Vandebriel; Henk Van Loveren
Journal:  Toxicol Sci       Date:  2002-04       Impact factor: 4.849

9.  Information-theoretic model-averaged benchmark dose analysis in environmental risk assessment.

Authors:  Walter W Piegorsch; Lingling An; Alissa A Wickens; R Webster West; Edsel A Peña; Wensong Wu
Journal:  Environmetrics       Date:  2013-05-01       Impact factor: 1.900

10.  Update: use of the benchmark dose approach in risk assessment.

Authors:  Anthony Hardy; Diane Benford; Thorhallur Halldorsson; Michael John Jeger; Katrine Helle Knutsen; Simon More; Alicja Mortensen; Hanspeter Naegeli; Hubert Noteborn; Colin Ockleford; Antonia Ricci; Guido Rychen; Vittorio Silano; Roland Solecki; Dominique Turck; Marc Aerts; Laurent Bodin; Allen Davis; Lutz Edler; Ursula Gundert-Remy; Salomon Sand; Wout Slob; Bernard Bottex; Jose Cortiñas Abrahantes; Daniele Court Marques; George Kass; Josef R Schlatter
Journal:  EFSA J       Date:  2017-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.